Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Non Operating Income (2016 - 2025)

Historic Non Operating Income for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to -$37000.0.

  • International Stem Cell's Non Operating Income fell 571.43% to -$37000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$156000.0, marking a year-over-year decrease of 1555.56%. This contributed to the annual value of -$141000.0 for FY2024, which is 12650.38% down from last year.
  • International Stem Cell's Non Operating Income amounted to -$37000.0 in Q3 2025, which was down 571.43% from -$38000.0 recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Non Operating Income peaked at $636000.0 during Q2 2023, and registered a low of -$43000.0 during Q3 2022.
  • In the last 5 years, International Stem Cell's Non Operating Income had a median value of -$34000.0 in 2022 and averaged $63736.8.
  • Per our database at Business Quant, International Stem Cell's Non Operating Income plummeted by 33333.33% in 2021 and then surged by 202727.27% in 2023.
  • Quarter analysis of 5 years shows International Stem Cell's Non Operating Income stood at -$28000.0 in 2021, then plummeted by 35.71% to -$38000.0 in 2022, then rose by 10.53% to -$34000.0 in 2023, then fell by 17.65% to -$40000.0 in 2024, then increased by 7.5% to -$37000.0 in 2025.
  • Its last three reported values are -$37000.0 in Q3 2025, -$38000.0 for Q2 2025, and -$41000.0 during Q1 2025.